¿Se pueden disminuir las dosis de hidroxicloroquina en pacientes con lupus en remisión prolongada?
Resumen
Carta al editor
Citas
(1) Urowitz MB, Gladman DD, Tom BDM, Ibañez D, Farewell VT. Changing patterns in mortality and disease outcomes for patients with systemic lupus erythematosus. J Rheumatol 2008; 35(11):2152-8.
(2) Ruiz-Irastorza G, Khamashta MA. Hydroxychloroquine: the cornerstone of lupus therapy. Lupus 2008; 17(4):271-3.
(3) Gómez-Puerta JA, Pons-Estel BA, Cervera R. Prolonged remission in SLE revisited: an old wine in a new bottle. J Rheumatol 2014; 41(9):1728-31.
(4) van Vollenhoven RF, Mosca M, Bertsias G, Isenberg D, Kuhn A, Lerstrøm K, et al. Treat-to-target in systemic lupus erythematosus: recommendations from an international task force. Ann Rheum Dis 2014; 73(6):958-67.
(5) Ruiz-Irastorza G, Ramos-Casals M, Brito-Zeron P, Khamashta MA. Clinical efficacy and side effects of antimalarials in systemic lupus erythematosus: a systematic review. Ann Rheum Dis 2010; 69(1):20-8.
(6) Danza A, Graña D, Goñi M, Vargas A, Ruiz-Irastorza G. Hidroxicloroquina en el tratamiento de las enfermedades autoinmunes sistémicas. Rev Méd Chile 2016; 144(2):232-40.
(7) Marmor MF, Kellner U, Lai TY, Melles RB, Mieler WF. Recommendations on Screening for Chloroquine and Hydroxychloroquine Retinopathy (2016 Revision). Ophthalmology 2016; 123(6):1386-94.
(8) Canadian Hydroxychloroquine Study Group. A randomized study of the effect of withdrawing hydroxychloroquine sulfate in systemic lupus erythematosus. N Engl J Med 1991; 324(3):150-4.
(9) Tsakonas E, Joseph L, Esdaile JM, Choquette D, Senécal JL, Cividino A, et al. A long-term study of hydroxychloroquine withdrawal on exacerbations in systemic lupus erythematosus. The Canadian Hydroxychloroquine Study Group. Lupus 1998; 7(2):80-5.
(10) Moroni G, Gallelli B, Quaglini S, Banfi G, Rivolta E, Messa P, et al. Withdrawal of therapy in patients with proliferative lupus nephritis: long-term follow-up. Nephrol Dial Transplant 2006; 21(6):1541-8.
(11) Jiménez-Alonso J, Vargas-Hitos JA, Navarrete-Navarrete N, Zamora-Pasadas M, Aguilar-Huergo S, Jáimez L, et al. Seguimiento de los pacientes con lupus eritematoso sistémico: lo que no está en las guías. Rev Clin Esp 2013; 213(9):453-6.
